Are you okay with unknowns?
41:43–42:48 · 65s
Leigh crystallizes the core dilemma for peptide users: without established risks, dosing, or mechanisms, you’re accepting truly unknown risk compared to approved drugs with known profiles.
41:43–42:48 · 65s
Leigh crystallizes the core dilemma for peptide users: without established risks, dosing, or mechanisms, you’re accepting truly unknown risk compared to approved drugs with known profiles.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.